Details:

Alternative Title:
MMWR Morb Mortal Wkly Rep
Publisher's site:
http://dx.doi.org/10.15585/mmwr.mm6648a2
Personal Author:
Dugan, Vivien G. ; Blanton, Lenee ; Elal, Anwar Isa Abd ; Alabi, Noreen ; Barnes, John ; ... More +
Dugan, Vivien G. ; Blanton, Lenee ; Elal, Anwar Isa Abd ; Alabi, Noreen ; Barnes, John ; Brammer, Lynnette ; Burns, Erin ; Cummings, Charisse N. ; Davis, Todd ; Flannery, Brendan ; Fry, Alicia M. ; Garg, Shikha ; Garten, Rebecca ; Gubareva, Larisa ; Jang, Yunho ; Kniss, Krista ; Kramer, Natalie ; Lindstrom, Stephen ; Mustaquim, Desiree ; O’Halloran, Alissa ; Olsen, Sonja J. ; Sessions, Wendy ; Taylor, Calli ; Trock, Susan ; Xu, Xiyan ; Wentworth, David E. ; Katz, Jacqueline ; Jernigan, Daniel Less -
Description:
Influenza activity in the United States was low during October 2017, but has been increasing since the beginning of November. Influenza A Viruses have been most commonly identified, with influenza A(H3N2) Viruses predominating. Several influenza activity indicators were higher than is typically seen for this time of year. The majority of influenza Viruses characterized during this period were genetically or antigenically similar to the 2017-18 Northern Hemisphere cell-grown vaccine reference Viruses. These data indicate that currently circulating Viruses have not undergone significant antigenic drift; however, circulating A(H3N2) Viruses are antigenically less similar to egg-grown A(H3N2) Viruses used for producing the majority of influenza vaccines in the United States It is difficult to predict which influenza Viruses will predominate in the 2017-18 influenza season; however, in recent past seasons in which A(H3N2) Viruses predominated, hospitalizations and deaths were more common, and the effectiveness of the vaccine was lower. Annual influenza vaccination is recommended for all persons aged ≥6 months who do not have Contraindications. Multiple influenza vaccines are approved and recommended for use during the 2017-18 season, and vaccination should continue to be offered as long as influenza Viruses are circulating and unexpired vaccine is available. This report summarizes U.S. influenza activity* during October 1-November 25, 2017 (Surveillance weeks 40-47).|.
Subjects:
[+]
Adolescent Adult Aged Child Child, Preschool Child Mortality Disease Outbreaks Drug Resistance, Viral Full Report Hospitalization Humans Infant Infant, Newborn Influenza, Human Influenza A Virus, H1N1 Subtype Influenza A Virus, H1N2 Subtype Influenza A Virus, H3N2 Subtype Influenza B Virus Middle Aged Outpatients Pneumonia Population Surveillance Young Adult
Source:
MMWR Morb Mortal Wkly Rep. 66(48):1318-1326.
Pubmed ID:
29216030
Pubmed Central ID:
PMC5757637
Document Type:
Journal Article
Place as Subject:
United States
Collection(s):
Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:
[+]
urn:sha256:af5b40b32e28de1eea964d16651fdd12ea5269760960aa68344bf19705bfdfe0
Download URL:
https://stacks.cdc.gov/view/cdc/54307/cdc_54307_DS1.pdf
File Type:

Supporting Files

• 	mm6648a2.nxml	xml
  	mm6648a2-F1.gif	gif
  	mm6648a2-F1.jpg	jpeg
  	mm6648a2-F2.gif	gif
  	mm6648a2-F2.jpg	jpeg
  	mm6648a2-F3.gif	gif
  	mm6648a2-F3.jpg	jpeg
  	mm6648a2-F4.gif	gif
  	mm6648a2-F4.jpg	jpeg

More +